Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
[Objective] Hyperferritinaemia is associated with liver fibrosis severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), but the longitudinal implications have not been thoroughly investigated. We assessed the role of serum ferritin in predicting long-term outcome...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/388271 |
| Acceso en línea: | http://hdl.handle.net/10261/388271 https://api.elsevier.com/content/abstract/scopus_id/85183300408 |
| Access Level: | acceso abierto |
| Palabra clave: | Fibrosis Nonalcoholic steatohepatitis |
| Sumario: | [Objective] Hyperferritinaemia is associated with liver fibrosis severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), but the longitudinal implications have not been thoroughly investigated. We assessed the role of serum ferritin in predicting long-term outcomes or death. |
|---|